Prognostic risk score for patients with relapsed or refractory chronic lymphocytic leukaemia treated with targeted therapies or chemoimmunotherapy: a retrospective, pooled cohort study with external validations-Reference-Cited by-同舟云学术

Prognostic risk score for patients with relapsed or refractory chronic lymphocytic leukaemia treated with targeted therapies or chemoimmunotherapy: a retrospective, pooled cohort study with external validations

Published:2019-07 Issue:7 Volume:6 Page:e366-e374
ISSN:2352-3026
Container-title:The Lancet Haematology
language:en
Short-container-title:The Lancet Haematology

Author:

Soumerai Jacob D,Ni Ai,Darif Mohamed,Londhe Anil,Xing Guan,Mun Yong,Kay Neil E,Shanafelt Tait D,Rabe Kari G,Byrd John C,Chanan-Khan Asher A,Furman Richard R,Hillmen Peter,Jones Jeffrey,Seymour John F,Sharman Jeffrey P,Ferrante Lucille,Mobasher Mehrdad,Stark Thomas,Reddy Vijay,Dreiling Lyndah K,Bhargava Pankaj,Howes Angela,James Danelle F,Zelenetz Andrew D

Funder

Lymphoma Research Foundation under Clinical Investigator Career Development Award

National Institutes of Health/National Cancer Institute Core Grant

Publisher

Elsevier BV

Subject

Hematology

Reference31 articles.

1. Clinical staging of chronic lymphocytic leukemia. Blood;Rai;Blood,1975

2. A new prognostic classification of chronic lymphocytic leukemia derived from a multivariate survival analysis;Binet;Cancer,1981

3. Unmutated Ig VH genes are associated with a more aggressive form of chronic lymphocytic leukemia;Hamblin;Blood,1999

4. Gene mutations and treatment outcome in chronic lymphocytic leukemia: results from the CLL8 trial;Stilgenbauer;Blood,2014

5. Genomic aberrations and survival in chronic lymphocytic leukemia;Döhner;N Engl J Med,2000

Cited by 48 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prognostic Markers in the Era of Targeted Therapies;Acta Haematologica;2023-09-13

2. Relapsed/Refractory Chronic Lymphocytic Leukemia (CLL);Current Hematologic Malignancy Reports;2023-06-06

3. Approach to relapsed CLL including Richter Transformation;Hematological Oncology;2023-06

4. Assessment of Impact of Human Leukocyte Antigen-Type and Cytokine-Type Responses on Outcomes after Targeted Therapy Currently Used to Treat Chronic Lymphocytic Leukemia;Journal of Clinical Medicine;2023-04-06

5. Prognostic models predicting overall survival of chronic lymphocytic leukemia (CLL) patients treated with ibrutinib-based therapies: a systematic review and meta-analysis;Leukemia & Lymphoma;2023-02-27